Bioinformatic analysis performed by Zou et al. revealed that high TMEM213 expression was associated with resistance to paclitaxel in patients with lung adenocarcinoma, which was related to cytochrome P450 and ABC transporters [30]. The gene discussed is TMEM213; the disease is lung adenocarcinoma.